Friends
On my blog in my interview from iwCLL 2013, Professor Hallek discusses who should consider CIT (chemo-imminotherapy) and who should not. This is very important topic for anyone considering treatment.
Brian Koffman
iwCLL 2013: Prof Hallek Discusses a Focused Ro... - CLL Support
iwCLL 2013: Prof Hallek Discusses a Focused Role of Chemo-Immunotherapy
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
2 Replies
•
Thanks Brian, and a Healthy and Happy New Year to you.
Many thanks for these videos, please keep them coming.Best wishes
Not what you're looking for?
You may also like...
iwCLL 2013: Dr. Sharman discusses why we feel so lousy, and much more.
Hi friends
In Part 4 of my conversation with Dr. Sharman at iwCLL 2013, we start by discussing the...
How taxing is the role of caregiver during chemo?
I'm 71 years old and retired, just completing 4 years of watch and wait, asymptomatic except for...
The unspeakable side effects of a bit of chemo ( bums and faries)
Well, what can I say... Recovering well from the trauma of the first round of FCR BUT now...
EHA 2019: Dr. Maloney on CAR-T and Dr. Davids of Chemo-Immunotherapy combinations
David Maloney is world expert in CAR-T therapy and was one of my doctors when I got my genetically...
Chemo-free treatment with acalabrutinib can benefit CLL/SLL patients never treated before: a plain language summary of the ELEVATE-TN study
The ELEVATE-TN international study commenced in September 2015. The plain language article...
my numbers on 05/09/2020
Alochol and CLL treatment
Ibrutinib. Capsules are being discontinued and replaced by tablets.
My GP just said something about CLL and Covid
